Hirota Fujiki
Faculty of Pharmaceutical Sciences
Tokushima Bunri University
Japan
Name/email consistency: high
- Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development. Fujiki, H., Suganuma, M. Anticancer. Agents. Med. Chem (2011)
- Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors. Fujiki, H., Suganuma, M. Prog. Mol. Subcell. Biol. (2009)
- Green tea: Health benefits as cancer preventive for humans. Fujiki, H. Chem. Rec (2005)
- Carcinogenic potential of tobacco tar-resistant Staphylococcus aureus in buccal cavity. Fujiki, H., Takeuchi, H., Nishitani, N., Yamanaka, H., Suzuki, K., Kurusu, M., Suganuma, M. J. Cancer Res. Clin. Oncol. (2004)
- New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Fujiki, H., Suganuma, M., Kurusu, M., Okabe, S., Imayoshi, Y., Taniguchi, S., Yoshida, T. Mutat. Res. (2003)
- Green tea: cancer preventive beverage and/or drug. Fujiki, H., Suganuma, M., Imai, K., Nakachi, K. Cancer Lett. (2002)
- Involvement of TNF-alpha changes in human cancer development, prevention and palliative care. Fujiki, H., Suganuma, M., Okabe, S., Kurusu, M., Imai, K., Nakachi, K. Mech. Ageing Dev. (2002)









